Epidemiologie

Epidemiologie erforscht Gesundheit und Krankheit auf der Bevölkerungsebene – die Infektionsepidemiologie beschäftigt sich mit übertragbaren Krankheiten. Ihre Werkzeuge und Methoden sind systematische Befragungen, klinische Untersuchungen und labordiagnostische Nachweise sowie statistische Analysen. So können Ursachen und Risikofaktoren für Infektionen identifiziert werden. Die Infektionsepidemiologie trägt zur Entwicklung von Präventionsmaßnahmen, ebenso wie zur Früherkennung und Therapie von Erkrankungen bei. Zudem überprüft sie die Wirksamkeit solcher Maßnahmen.

Leitung

Team

Prof. Dr. Gérard Krause

Abteilungsleiter Epidemiologie

Publikationen

2017

Adeoye O, Tom-Aba D, Ameh C, Ojo O, Ilori E, Gidado S, Waziri E, Nguku P, Mall S, Denecke K, Lamshoeft M, Schwarz N, Krause G, Poggensee G. Implementing Surveillance and Outbreak Response Management and Analysis System (SORMAS) for Public Health in West Africa- Lessons Learnt and Future Direction. International Journal of TROPICAL DISEASE & Health. 2017;22(2):1-17.

Cuny C, Arnold P, Hermes J, Eckmanns T, Mehraj J, Schoenfelder S, Ziebuhr W, Zhao Q, Wang Y, Fessler AT, Krause G, et al. Occurrence of cfr-mediated multiresistance in staphylococci from veal calves and pigs, from humans at the corresponding farms, and from veterinarians and their family members. Vet Microbiol. 2017;200:88-94.

Karo B, Krause G, Castell S, Kollan C, Hamouda O, Haas W. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. BMC Infectious Diseases. 2017;17(1).

Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades - A global analysis. J Hepatol. 2017;66(1):48-54.

Schweitzer A, Akmatov MK, Krause G. Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bulletin of the World Health Organization. 2017;95(3):199-209G.

2016

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W. Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS. 2016;30(7):1089-98.

Klett-Tammen CJ, Krause G, Seefeld L, Ott JJ. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health. 2016;16(1):121.

Klett-Tammen CJ, Krause G, von Lengerke T, Castell S. Advising vaccinations for the elderly: a cross-sectional survey on differences between general practitioners and physician assistants in Germany. BMC Fam Pract. 2016;17(1):98.

Mehraj J, Witte W, Akmatov MK, Layer F, Werner G, Krause G. Epidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community. Curr Top Microbiol Immunol. 2016;398:55-87.

Moyer D, Tom-Aba D, Sharma S, Krause G. Taking Digital Innovation into the Field of Infectious Diseases: The Case of SORMAS®. In: Oswald GK, M., editor. Shaping the Digital Enterprise: Springer; 2016. p. 219-36.

Ott JJ, Horn J. Changing hepatitis B virus epidemiology in rural China. Lancet Infect Dis. 2016;16(2):150.

Smieszek T, Castell S, Barrat A, Cattuto C, White PJ, Krause G. Contact diaries versus wearable proximity sensors in measuring contact patterns at a conference: method comparison and participants’ attitudes. BMC Infectious Diseases. 2016;16(1):341.

2015

Akmatov MK, Kimani-Murage E, Pessler F, Guzman CA, Krause G, Kreienbrock L, Mikolajczyk RT. Evaluation of invalid vaccine doses in 31 countries of the WHO African Region. Vaccine. 2015;33(7):892-901.

Akmatov MK, Rübsamen N, Schultze A, Kemmling Y, Obi N, Günther K, Ahrens W, Pessler F, Krause G, Mikolajczyk RT. Diverse recruitment strategies result in different participation percentages in a web-based study, but in similar compliance. International journal of public health. 2015;60(8):937-43.

Fähnrich C, Denecke K, Adeoye OO, Benzler J, Claus H, Kirchner G, Mall S, Richter R, Schapranow MP, Schwarz N, Tom-Aba D, Uflacker M, Poggensee G, Krause G. Surveillance and Outbreak Response Management System (SORMAS) to support the control of the Ebola virus disease outbreak in West Africa. Euro Surveill. 2015;20(12).

Harder T, Abu Sin M, Bosch-Capblanch X, Bruno C, de Carvalho Gomes H, Duclos P, Eckmanns T, Elder R, Ellis S, Forland F, Garner P, James R, Jansen A, Krause G, Levy-Bruhl D, Morgan A, Meerpohl JJ, Norris S, Rehfuess E, Sanchez-Vivar A, Schunemann H, Takla A, Wichmann O, Zingg W, Zuiderent-Jerak T. Towards a framework for evaluating and grading evidence in public health. Health policy. 2015;119(6):732-6.

Mohr O, Schink SB, Eckmanns T, Krause G. Tuberculosis in public ground transport - is there enough evidence to justify contact tracing? Expert review of anti-infective therapy. 2015;13(1):1-3.

Rübsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, Zoch B, Krause G, Mikolajczyk RT. Ebola risk perception in Germany, 2014. Emerging infectious diseases. 2015;21(6):1012-8.

Santos-Hövener C, Marcus U, Koschollek C, Oudini H, Wiebe M, Ouedraogo OI, Thorlie A, Bremer V, Hamouda O, Dierks ML, An der Heiden M, Krause G. Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices. BMC Public Health. 2015;15(1):753.

Santos-Hövener C, Marcus U, Koschollek C, Oudini H, Wiebe M, Ouedraogo OI, Mayamba P, M’bayo R, Sanogo A, Bakambamba A, Gangarova T, Hamouda O, Dierks M-L, Krause G. Konzeption einer Studie zu sexueller Gesundheit bei in Deutschland lebenden Afrikanern. Prävention und Gesundheitsförderung. 2015;10(1):68-75.

Schweitzer A, Akmatov MK, Kindler F, Kemmling Y, Kreienbrock L, Krause G, Pessler F. The impact of distance and duration of travel on participation rates and participants' satisfaction: results from a pilot study at one study centre in Pretest 2 of the German National Cohort. BMJ open. 2015;5(8):e007461.

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55.

Schweitzer A, Krause G, Pessler F, Akmatov MK. Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan. BMC Public Health. 2015;15(1):798.

2014

Akmatov MK, Mehraj J, Gatzemeier A, Strömpl J, Witte W, Krause G, Pessler F. Serial home-based self-collection of anterior nasal swabs to detect Staphylococcus aureus carriage in a randomized population-based study in Germany. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2014;25:4-10.

Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O. [Seasonal and pandemic influenza vaccination: coverage and attitude among private physicians in Germany]. Gesundheitswesen. 2014;76(1):44-7.

Castell S, Akmatov MK, Obi N, Flesh-Janys D, Nieters A, Kemmling Y, Pessler F, Krause G. Test-retest reliability of an infectious disease questionnaire and evaluation of self-assessed vulnerability to infections : findings of Pretest 2 of the German National Cohort. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1300-7.

Castell S, Krause G, Schmitt M, Pawlita M, Delere Y, Obi N, Flesch-Janys D, Kemmling Y, Kaufmann AM. Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1270-6.

Hamouda O, Krause G, Pigeot I. [National Cohort -- the largest health study in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1243-5.

Harder T, Takla A, Rehfuess E, Sanchez-Vivar A, Matysiak-Klose D, Eckmanns T, Krause G, de Carvalho Gomes H, Jansen A, Ellis S, Forland F, et al. Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools. BMC medical research methodology. 2014;14(69):69.

Linseisen J PA, Pischon T, Willich S, Keil T, Boeing H, Ahrens W, Zeeb H, Kuss O, Giani G, Hoffmann B, Jöckel KH, Moebus S, Michels K, Schmoor C, Stang A, Haerting J, Flesch-Janys D, Obi N, Krause G, Lieb W, Nöthlings U, Löffler M, Thiery J, Kaaks R, Greiser KH, Becher H, Berger K, Hense HW, Völzke H, Hoffman W, Leitzmann M, Heid IM, Brenner H, Stegmaier C, Kurth BM, Schlaud M, Mueller UO, Bamberg F, Swart E, Günther M, Ahrens W, Hoffmann W, Jöckel KH, Kaaks R, Gromer B, Greiser KH, Linseisen J, Schmidt B, Wichmann HE, Weg-Remers S. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 2014;29(5):371-82.

Mall S, Akmatov MK, Schultze A, Ahrens W, Obi N, Pessler F, Krause G. Web-based questionnaires to capture acute infections in long-term cohorts : findings of a feasibility study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1308-14.

Mehraj J, Akmatov MK, Strompl J, Gatzemeier A, Layer F, Werner G, Pieper DH, Medina E, Witte W, Pessler F, Krause G. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PloS one. 2014;9(9):e107937.

Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G, Gibbons CL, A VANL, Mc DS, Brooke RJ, Kramarz P, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiology and infection. 2014;142(10):2024-35.

Schultze A, Akmatov MK, Andrzejak M, Karras N, Kemmling Y, Maulhardt A, Wieghold S, Ahrens W, Günther K, Schlenz H, Krause G, et al. Comparison of stool collection on site versus at home in a population-based study : feasibility and participants' preference in Pretest 2 of the German National Cohort. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1264-9.

Schultze A, Akmatov MK, Castell S, Karch A, Ahrens W, Gunther K, Schlenz H, Flesch-Janys D, Obi N, Pessler F, Krause G. Collection of vaccination data in the German National Cohort : Findings of a feasibility study in three study centers. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1292-9.

Sievers C, Akmatov MK, Kreienbrock L, Hille K, Ahrens W, Gunther K, Flesch-Janys D, Obi N, Michels KB, Fricke J, Greiser KH, Kaaks R, Peter HH, Pessler F, Nieters A, Krause G. Evaluation of a questionnaire to assess selected infectious diseases and their risk factors : findings of a multicenter study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(11):1283-91.

2013

Balabanova Y, Klar S, Delere Y, Wilking H, Faber MS, Lassen SG, Gilsdorf A, Dupke S, Nitschke M, Sayk F, Grunow R, Krause G. Serological evidence of asymptomatic infections during Escherichia coli O104:H4 outbreak in Germany in 2011. PloS one. 2013;8(9):e73052.

Buchholz U, Muller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, Bonin F, Drosten C, Schweiger B, Wolff T, Muth D, Meyer B, Buda S, Krause G, Schaade L, Haas W. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18(8).

Cediel-Becerra NM, Krause G. Herramientas para la toma de decisiones en salud pública basadas en la evidencia y priorización de enfermedades. Rev salud pública. 2013;15(5):694-706.

Heideking M, Lander F, Hufnagel M, Pfeifer Y, Wicker E, Krause G, Berner R. Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2013;32(9):1221-3.

Krause G, Frank C, Gilsdorf A, Mielke M, Schaade L, Stark K, Burger R. [The 2011 HUS epidemic in Germany. Challenges for disease control: what should be improved?]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(1):56-66.

Krause G. Electronic surveillance for infectious diseases in Germany. In: M’ikanatha NM, Lynfield R, Van Beneden CA, de Valk H, editors. Infectious Disease Surveillance. 2nd ed: Wiley-Blackwell; 2013. p. 426-33.

Mohr O, Hermes J, Schink SB, Askar M, Menucci D, Swaan C, Goetsch U, Monk P, Eckmanns T, Poggensee G, Krause G. Development of a risk assessment tool for contact tracing people after contact with infectious patients while travelling by bus or other public ground transport: a Delphi consensus approach. BMJ open. 2013;3(10):e002939.

Ultsch B, Köster I, Reinhold T, Siedler A, Krause G, Icks A, Schubert I, Wichmann O. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. The European journal of health economics : HEPAC : health economics in prevention and care. 2013;14(6):1015-26.

Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC health services research. 2013;13:359.

2012

Askar MA, Mohr O, Eckmanns T, Krause G, Poggensee G. Quantitative assessment of passenger flows in Europe and its implications for tracing contacts of infectious passengers. Euro Surveill. 2012;17(24).

Böhmer MM, Walter D, Falkenhorst G, Muters S, Krause G, Wichmann O. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health. 2012;12:938.

Dehnert M, Fingerle V, Klier C, Talaska T, Schlaud M, Krause G, Wilking H, Poggensee G. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS). PloS one. 2012;7(8):e41321.

Klein S, Schöneberg I, Krause G. [The historical development of immunization in Germany. From compulsory smallpox vaccination to a National Action Plan on Immunization]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(11-12):1512-23.

Laude G, Kist M, Krause G. [Networks of National Reference Centers and associated Consiliary Laboratories in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(2):223-30.

Mohr O, Askar M, Schink S, Eckmanns T, Krause G, Poggensee G. Evidence for airborne infectious disease transmission in public ground transport--a literature review. Euro Surveill. 2012;17(35).

Schweickert B, Noll I, Feig M, Claus H, Krause G, Velasco E, Eckmanns T. MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012;31(8):1855-65.

STEC Workshop Reporting Group [Krause G. being a member of this group]. Experiences from the Shiga toxin-producing Escherichia coli O104:H4 outbreak in Germany and research needs in the field, Berlin, 28-29 November 2011.  Euro Surveill2012.

Suess T, Remschmidt C, Schink SB, Schweiger B, Heider A, Milde J, Nitsche A, Schroeder K, Doellinger J, Braun C, Haas W, Krause G, Buchholz U. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PloS one. 2012;7(12):e51653.

Suess T, Remschmidt C, Schink SB, Schweiger B, Nitsche A, Schroeder K, Doellinger J, Milde J, Haas W, Koehler I, Krause G, et al. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011. BMC infectious diseases. 2012;12:26.

Velasco E, Noll I, Espelage W, Ziegelmann A, Krause G, Eckmanns T. A survey of outpatient antibiotic prescribing for cystitis. Deutsches Arzteblatt international. 2012;109(50):878-84.

Velasco E, Ziegelmann A, Eckmanns T, Krause G. Eliciting views on antibiotic prescribing and resistance among hospital and outpatient care physicians in Berlin, Germany: results of a qualitative study. BMJ open. 2012;2(1):e000398.

Walter D, Bohmer M, Reiter S, Krause G, Wichmann O. Risk perception and information-seeking behaviour during the 2009/10 influenza A(H1N1)pdm09 pandemic in Germany. Euro Surveill. 2012;17(13).

Werber D, Krause G, Frank C, Fruth A, Flieger A, Mielke M, Schaade L, Stark K. Outbreaks of virulent diarrheagenic Escherichia coli--are we in control? BMC medicine. 2012;10:11.

Wicker S, Gottschalk R, Wolff U, Krause G, Rabenau HF. [Influenza vaccination rates in Hessian hospitals]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(8):932-6.

Wilking H, Gotsch U, Meier H, Thiele D, Askar M, Dehnert M, Frank C, Fruth A, Krause G, Prager R, Stark K, et al. Identifying risk factors for shiga toxin-producing Escherichia coli by payment information. Emerging infectious diseases. 2012;18(1):169-70.

2011

Alpers A, Weist K, Eckmanns T, Krause G. Untersuchung von Infektionsausbrüchen im Krankenhaus. In: Eikmann T, Christiansen B, Exner M, editors. Hygiene in Krankenhaus und Praxis: Ecomed; 2011. p. 73-85

Altmann M, Spode A, Altmann D, Wadl M, Benzler J, Eckmanns T, Krause G, An der Heiden M. Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011. Emerging infectious diseases. 2011;17(10):1906-9.

Amato-Gauci A, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, Penttinen P, Nicoll A, on behalf of European Influenza Surveillance Network (EISN)[Krause G being member of EISN]. Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe. 2011. Report No.: 1560-7917 (Electronic)

Askar M, Faber MS, Frank C, Bernard H, Gilsdorf A, Fruth A, Prager R, Hohle M, Suess T, Wadl M, Krause G, et al. Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011. Euro Surveill. 2011;16(22).

Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gartner B, Gross U, Haas W, Hamouda O, Hubner J, Janisch T, Kist M, Kramer MH, Ledig T, Mielke M, Pulz M, Stark K, Suttorp N, Ulbrich U, Wichmann O, Krause G. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PloS one. 2011;6(10):e25691.

Böhmer MM, Walter D, Krause G, Muters S, Gosswald A, Wichmann O. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Human vaccines. 2011;7(12):1317-25.

Böhmer MM, Walter D, Muters S, Krause G, Wichmann O. Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey. Vaccine. 2011;29(27):4492-8.

Buchholz U, Bernard H, Werber D, Bohmer MM, Remschmidt C, Wilking H, Delere Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Hohle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. The New England journal of medicine. 2011;365(19):1763-70.

Dudareva S, Schweiger B, Thamm M, Hohle M, Stark K, Krause G, Buda S, Haas W. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PloS one. 2011;6(6):e21340.

Frank C, Faber MS, Askar M, Bernard H, Fruth A, Gilsdorf A, Hohle M, Karch H, Krause G, Prager R, Spode A, et al. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. Euro Surveill. 2011;16(21).

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Muller L, King LA, Rosner B, Buchholz U, Stark K, Krause G. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. The New England journal of medicine. 2011;365(19):1771-80.

Gilsdorf A, Krause G. Authors reply: Prioritisation of infectious diseases in public health: feedback on the prioritisation methodology, 15 July 2008 to 15 January 2009. Euro Surveill. 2011;16(27).

Gilsdorf A, Krause G. Prioritisation of infectious diseases in public health: feedback on the prioritisation methodology, 15 July 2008 to 15 January 2009. Euro Surveill. 2011;16(18).

Siedler A, Mankertz A, Feil F, Ahlemeyer G, Hornig A, Kirchner M, Beyrer K, Dreesman J, Scharkus S, Marcic A, Reiter S, Matysiak-Klose D, Santibanez S, Krause G, Wichmann O. Closer to the goal: efforts in measles elimination in Germany 2010. The Journal of infectious diseases. 2011;204 Suppl 1:S373-80.

Suess T, Remschmidt C, Schink S, Luchtenberg M, Haas W, Krause G, Buchholz U. Facemasks and intensified hand hygiene in a German household trial during the 2009/2010 influenza A(H1N1) pandemic: adherence and tolerability in children and adults. Epidemiology and infection. 2011;139(12):1895-901.

Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC infectious diseases. 2011;11:173.

Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. PIH15 Estimating Herpes Zoster Disease Burden in Germany. Value in Health. 2011;14(7):A400.

Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzalez C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS medicine. 2011;8(7):e1001053.

Velasco E, Espelage W, Faber M, Noll I, Ziegelmann A, Krause G, Eckmanns T. A national cross-sectional study on socio-behavioural factors that influence physicians' decisions to begin antimicrobial therapy. Infection. 2011;39(4):289-97.

Wadl M, Rieck T, Nachtnebel M, Greutelaers B, an der Heiden M, Altmann D, Hellenbrand W, Faber M, Frank C, Schweickert B, Krause G, et al. Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011. Euro Surveill. 2011;16(24).

Walter D, Böhmer MM, Heiden M, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine. 2011;29(23):4008-12.

News

Video

  • SORMAS - die Zukunft der Seuchenüberwachung

    Epidemiologen und IT-Experten aus Deutschland und Nigeria haben gemeinsam eine innovative App entwickelt, die helfen soll Epidemien wie Ebola oder Cholera zu bekämpfen - das Surveillance Outbreak Response Management and Analysis System (SORMAS). Unser Video zeigt, warum eine Anwendung wie SORMAS dringend benötigt wird und wie das einzigartige Konzept SORMAS so vielversprechend macht:

  • Was versteht man unter Infektionsepidemiologie?

    Was heißt "Infektionsepidemiologie"? Auf diese Frage antwortet Prof. Dr. Gérard Krause, Abteilungsleiter Epidemiologie am HZI in Braunschweig.

  • Mit der SORMAS-App gegen Epidemien in Nigeria

    Mit einem neuen mobilen Informationssystem bekämpfen deutsche Wissenschaftler vom Braunschweiger Helmholtz-Zentrum für Infektionsforschung (HZI) und nigerianische Forscher erstmals einen Affenpocken-Ausbruch in Nigeria. SORMAS – so der Name des Systems – steht für „Surveillance, Outbreak Response Management and Analysis System“. Wie das mobile Epidemie-Management-System funktioniert, das erklärt Prof. Gérard Krause vom HZI kurz und knapp in einer Minute.

Audio Podcast

  • Staphylococcus aureus – ein Leben in der Nase2000 zufällig ausgewählte Braunschweiger Bürger haben in diesem Juni Post vom HZI erhalten – mit der Bitte, an einer Studie über die Verbreitung von Staphylococcus aureus teilzunehmen. Varianten des Bakteriums sind unter dem Kürzel MRSA als Krankenhauskeime zu trauriger Berühmtheit gelangt. Unsere Wissenschaftler wollen nun erforschen, wie viele Gesunde – außerhalb von Krankenhäusern – mit diesem Keim Leben. Und sie suchen nach Risikofaktoren, die Staphylococcus aureus die Besiedlung des Menschen erleichtern. Begleiten Sie Frank Pessler und Jaishri Mehraj ein Stück in die Welt der Epidemiologie...
  • Proben und Fragebögen für die Infektionsforschung - Die Nationale Kohorte Diabetes mellitus, Krebs, Arterienverkalkung und diverse Infektionen sind Volkskrankheiten, über die wir viel zu wenig wissen. Mit der Nationalen Kohorte wollen Wissenschaftler diesen Krankheiten auf den Grund gehen und neue Strategien gegen sie entwickeln. Frank Pessler und Manas Akmatov nehmen die Infektionen ins Visier. Lassen Sie sich erklären, wie ihnen 225.000 Menschen dabei helfen sollen…
DruckenPer Mail versendenTeilen